The purpose of the Behavioral Assessment core (BAC) is to document neurobehavioral manifestations present in murine and rhesus monkey animal models which reflect pathological changes reminiscent of those seen in HIV+ patients, relevant, state of the art assays will target behaviors known to be impaired in patients with NeuroAids and associated with affected brain regions. To fulfill this goal the BAC will provide services for 1) demonstrating that viral disease models produce functional changes reflected in behavioral pathology, and 2) evaluating the therapeutic potential for novel agents using behavioral endpoints. The availability of the BAC will permit Scripps NeuroAIDS Preclinical Studies (SNAPS) PI's to obtain behavioral assays of animal models and target compounds using a novel level of analysis that has clinical relevance for the study of NeuroAIDS.
Specific Aims of the BAC are to provide behavioral testing in mouse models of viral pathogenesis including 1) Basic physiological measures, 2) Motor ability and exploration, 3) Learning and memory function, and in SIV-infected macaques, 4) Psychomotor performance, 5) Scheduled-controlled responding, 6) Complex, cognition assessed using tested based on a human battery. Additionally the BAC will be involved in 7) Behavioral analysis of novel compounds, 8) Advice and training for behavioral assessment, and 9) Close interactions with the other cores for education, outreach and collaborative activities of the CSPAR. The BAC is designed to be flexible according to the outreach and collaborative activities of the CSPAR. The BAC is designed to be flexible according to the strategic needs and priorities for the entire CSPAR set by the CSPAR Director, PI's, and the advisory boards. The BAC will solicit advice from these individuals regarding core policies, services and maintenance of collaborations among the BAC, other research cores, and potential new users. The Core director will communicate with SNAPS PI's to determine their current and future expectations for BAC services in order to ensure state of the art services that meet the needs of the CSPAR. Performance and output of the BAC will be evaluated by the efficient and timely acquisition of data leading to high quality publications and by the development of new projects related to work conducted by the Core.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
1P30MH062261-01
Application #
6221860
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2000-09-30
Project End
2005-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Olson, Katherine E; Bade, Aditya N; Namminga, Krista L et al. (2018) Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice. J Neurovirol 24:398-410
Hu, Guoku; Liao, Ke; Niu, Fang et al. (2018) Astrocyte EV-Induced lincRNA-Cox2 Regulates Microglial Phagocytosis: Implications for Morphine-Mediated Neurodegeneration. Mol Ther Nucleic Acids 13:450-463
Schutt, Charles R; Gendelman, Howard E; Mosley, R Lee (2018) Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease. Mol Neurodegener 13:26
Sillman, Brady; Bade, Aditya N; Dash, Prasanta K et al. (2018) Creation of a long-acting nanoformulated dolutegravir. Nat Commun 9:443
Domingo-Almenara, Xavier; Montenegro-Burke, J Rafael; Benton, H Paul et al. (2018) Annotation: A Computational Solution for Streamlining Metabolomics Analysis. Anal Chem 90:480-489
Thomas, Midhun B; Gnanadhas, Divya Prakash; Dash, Prasanta K et al. (2018) Modulating cellular autophagy for controlled antiretroviral drug release. Nanomedicine (Lond) 13:2139-2154
Spooner, Rachel K; Wiesman, Alex I; Mills, Mackenzie S et al. (2018) Aberrant oscillatory dynamics during somatosensory processing in HIV-infected adults. Neuroimage Clin 20:85-91
Kiyota, Tomomi; Machhi, Jatin; Lu, Yaman et al. (2018) URMC-099 facilitates amyloid-? clearance in a murine model of Alzheimer's disease. J Neuroinflammation 15:137
Guijas, Carlos; Montenegro-Burke, J Rafael; Warth, Benedikt et al. (2018) Metabolomics activity screening for identifying metabolites that modulate phenotype. Nat Biotechnol 36:316-320
Kevadiya, Bhavesh D; Woldstad, Christopher; Ottemann, Brendan M et al. (2018) Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution. Theranostics 8:256-276

Showing the most recent 10 out of 374 publications